Skip to main content
Equibles

LMED · LataMed AI Corp.

Track LMED — free

Use LMED with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LMED.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.05 -0.01 (-18.00%) At close · Oct 21
Rebalance outlook locked
Going-concern doubt — flagged Aug 11, 2026

Substantial doubt about the company's ability to continue as a going concern.

“During six months ended June 30, 2026, the Company incurred net losses of $140,221 and accumulated deficits of $29,741,007. These conditions raise substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 11, 2026
Market Cap
$1.99M
Shares
36.13M
Volume · Oct 21 5135 Avg daily vol (3M) 154.55K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.05 Open$0.05 Day$0.05–0.05 Available close range$0.03–1.25 Avg vol 30d148K Short int68K · 0.2% float · 1.0d Short vol46% DataJan 2020–Oct 2026 Filing10-Q · Aug 11

The closing range uses available history since Feb 10, 2026; less than a full year is stored.

Up next

Latest filing: 10-Q
filed Aug 11, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$294,069
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$0
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+59.5%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.2%
Latest settlement · 1.0 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 16.7 · calm Equity put/call 0.52
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −96%
below
Price vs 50-day avg −83%
below
RSI (14) 28
oversold
MACD trend Positive
52-week position 1%
near low
Momentum
relative strength
Very Weak
1-month return −36%
trailing
6-month return −89%
trailing
YTD return −65%
this year
Relative strength −96%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.19% of float · ▼ -50.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Squeeze score 22
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 731%
annualized · 1-yr
Max drawdown −100%
past year
ATR 58.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−96% Bearish
Price vs 50-day avg
−83% Bearish
RSI (14)
28 Neutral
MACD trend
Positive Bullish
52-week position
1% Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.19% of float · ▼ -50.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its available closing range
Range low $0 Now $0 · 1% Range high $1
vs 200-day avg -96% vs 50-day avg -83%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Software - Application — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
LMED
LataMed AI Corp.
this stock
$1.99M — — — 0.2%
QH
QUHUO Ltd
 $314.26B +228.7% +59.7% — 0.0%
SAP
Sap SE
 $264.29B -4.2% — — 0.4%
SHOP
Shopify Inc.
 $223.21B +8.3% +30.1% 116.4 1.6%
CRM
Salesforce, Inc.
 $198.98B -8.7% +25.9% 22.1 4.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Falling
Shares short
68.2K
Days to cover
1.0d
Change
-70.0K sh
View
Short Volume
Short vol %
46%
As of
Oct 20, 2026
Short Total
View
Fails to Deliver
FTD shares
53.6K
Value
$4.3K
As of
Sep 25, 2026
View
Off-Exchange
Off-exchange %
98.2%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-207.5K
EPS diluted
$-0.11
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 11, 2026
This year
12
View

Performance

5D 20D 120D MTD YTD
LMED -11.6% -35.7% -88.7% -24.8% -65.3%
SPY +0.5% +0.7% +7.6% +1.4% +13.4%
vs SPY -12.0% -36.4% -96.3% -26.2% -78.7%
Key facts CIK 1477960 CUSIP 21116R404 Visit website Investor relations